Quick Takeaways
- NTRA - Natera, Inc. has 18 insiders with reported activity on this page.
- Net insider value flow over the last year: -$265,301,699.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 18 Insiders of Natera, Inc.
- Symbol
- NTRA on Nasdaq
- Location
- Austin, TX
What Changed
- Buy value: ; sell value: $265,301,698.
- Net share flow: -1,313,942.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$265,301,699.
Buys
$0
Shares: 0
Insiders: 0
Sells
$265,301,699
Shares: 1,313,942
Insiders: 12
Net
-$265,301,699
Shares: -1,313,942
Insiders: -12
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 572,308 | $0 | $124,083,603 | -$124,083,603 |
| 3-6 | 0 | 428,019 | $0 | $90,773,624 | -$90,773,624 |
| 6-9 | 0 | 156,786 | $0 | $25,649,846 | -$25,649,846 |
| 9-12 | 0 | 156,829 | $0 | $24,794,625 | -$24,794,625 |
Natera, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN, Director | $477,632,400 | -$66,950,225 | -12% | Median | 06 Apr 2026 |
| Roelof Botha | Director | $264,997,107 | -$17,708,936 | -6.3% | Mixed | 30 Jan 2026 |
| James Healy | Director | $225,766,720 | Mixed | 25 Apr 2025 | ||
| Jonathan Sheena | Director, CO-FOUNDER | $59,953,838 | -$16,944,719 | -22% | Filing P/S | 18 Mar 2026 |
| Daniel Rabinowitz | Sec. And Chief Legal Officer | $46,468,951 | -$13,887,358 | -23% | Mixed | 01 Apr 2026 |
| John Fesko | President, Chief Bus. Officer | $38,621,702 | -$6,961,987 | -15% | Filing P/S | 09 Mar 2026 |
| Steven Leonard Chapman | CEO AND PRESIDENT, Director | $34,563,373 | -$87,418,800 | -72% | Mixed | 09 Mar 2026 |
| Solomon Moshkevich | President, Clinicaldiagnostics | $30,065,978 | -$15,980,081 | -35% | Filing P/S | 01 Apr 2026 |
| Michael Burkes Brophy | Chief Financial Officer | $13,821,871 | -$21,744,145 | -61% | Mixed | 09 Mar 2026 |
| Robert Alan Schueren | Chief Operating Officer | $9,082,035 | Mixed | 27 Jan 2023 | ||
| Herm Rosenman | Director | $4,682,828 | -$11,011,477 | -70% | Mixed | 30 Jan 2026 |
| Roy D. Baynes | Director | $4,221,899 | -$2,809,689 | -40% | Mixed | 30 Jan 2026 |
| Gail Boxer Marcus | Director | $1,548,587 | -$2,340,322 | -60% | Mixed | 30 Jan 2026 |
| Brinkley Ruth Williams | Director | $1,234,566 | Mixed | 30 Jan 2026 | ||
| Monica Bertagnolli | Director | $1,212,115 | Mixed | 30 Jan 2026 | ||
| Rowan E. Chapman | Director | $1,100,817 | -$1,543,960 | -58% | Filing P/S | 13 Mar 2026 |
| Todd C. Cozzens | Director | $1,038,936 | Mixed | 25 May 2022 | ||
| Eric Rubin | Director | Mixed | 26 Mar 2026 |
Top shareholders of Natera, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO |
13F
13D/G
|
Company |
9.1%
from 13D/G
|
12,854,334
|
$2,944,799,683 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.8%
|
12,306,424
|
$2,819,278,675 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
13F
|
T. Rowe Price Associates, Inc. · Company |
7.8%
|
10,872,702
|
$2,547,582,806 | -$309,081,133 | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.6%
from 13D/G
|
10,859,441
|
$2,487,789,346 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.6%
|
4,976,325
|
$1,140,026,295 | — | 31 Dec 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.8%
|
3,914,366
|
$896,742,107 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
3,225,879
|
$739,016,620 | — | 31 Dec 2025 | |
| COATUE MANAGEMENT LLC |
13F
|
Company |
1.9%
|
2,633,334
|
$603,270,486 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
2,608,644
|
$596,077,841 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.9%
|
2,599,299
|
$595,473,319 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.8%
|
2,534,553
|
$580,640,795 | — | 31 Dec 2025 | |
| Duquesne Family Office LLC |
13F
|
Company |
1.8%
|
2,511,357
|
$575,327,000 | — | 31 Dec 2025 | |
| Castle Hook Partners LP |
13F
|
Company |
1.6%
|
2,167,869
|
$496,637,110 | — | 31 Dec 2025 | |
| Matthew Rabinowitz |
3/4/5
|
EXECUTIVE CHAIRMAN, Director |
1.7%
|
2,388,162
|
$477,632,400 | -$66,950,225 | 06 Apr 2026 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.5%
|
2,047,963
|
$469,167,845 | — | 31 Dec 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,822,508
|
$417,518,357 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
1.2%
|
1,625,553
|
$372,397,937 | — | 31 Dec 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.1%
|
1,550,280
|
$355,153,645 | — | 31 Dec 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
1.1%
|
1,500,000
|
$343,635,000 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
1.1%
|
1,475,988
|
$338,134,121 | — | 31 Dec 2025 | |
| Capital World Investors |
13F
|
Company |
1%
|
1,433,094
|
$328,307,504 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.95%
|
1,329,166
|
$304,498,575 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.89%
|
1,234,154
|
$282,732,844 | — | 31 Dec 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.87%
|
1,219,045
|
$279,271,000 | — | 31 Dec 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.85%
|
1,179,939
|
$270,312,226 | — | 31 Dec 2025 | |
| Roelof Botha |
3/4/5
|
Director |
0.83%
|
1,156,738
|
$264,997,107 | -$17,708,936 | 30 Jan 2026 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.73%
|
1,019,195
|
$233,487,382 | — | 31 Dec 2025 | |
| James Healy |
3/4/5
|
Director |
1.1%
|
1,596,540
|
$225,766,720 | — | 25 Apr 2025 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
0.68%
|
944,028
|
$216,267,375 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.63%
|
875,373
|
$200,539,172 | — | 31 Dec 2025 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.59%
|
828,300
|
$189,755,182 | — | 31 Dec 2025 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.57%
|
790,101
|
$181,004,133 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.56%
|
775,774
|
$177,722,067 | — | 31 Dec 2025 | |
| NWI MANAGEMENT LP |
13F
|
Company |
0.55%
|
762,603
|
$174,705,000 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.53%
|
741,742
|
$169,925,675 | — | 31 Dec 2025 | |
| ARK Investment Management LLC |
13F
|
Company |
0.52%
|
731,110
|
$167,489,887 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.51%
|
716,781
|
$164,207,359 | — | 31 Dec 2025 | |
| PointState Capital LP |
13F
|
Company |
0.51%
|
715,495
|
$163,912,750 | — | 31 Dec 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.51%
|
714,692
|
$163,728,859 | — | 31 Dec 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.51%
|
711,394
|
$162,973,251 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
674,403
|
$154,499,006 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.47%
|
652,931
|
$149,580,057 | — | 31 Dec 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.45%
|
625,912
|
$143,390,180 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.44%
|
614,224
|
$141,141,841 | — | 31 Dec 2025 | |
| Chevy Chase Trust Holdings, LLC |
13F
|
Company |
0.42%
|
582,015
|
$133,333,817 | — | 31 Dec 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.4%
|
556,740
|
$127,543,566 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.4%
|
553,607
|
$126,825,827 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.39%
|
540,694
|
$123,867,649 | — | 31 Dec 2025 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.37%
|
521,750
|
$119,527,693 | — | 31 Dec 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
0.36%
|
498,359
|
$114,170,000 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for Natera, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Matthew Rabinowitz | NTRA | Common Stock | Tax liability | -1.15% | -27,610 | 2,383,162 | 06 Apr 2026 | Direct | ||
| Matthew Rabinowitz | NTRA | Common Stock | Options Exercise | 2.48% | 58,292 | 2,410,772 | 06 Apr 2026 | Direct | ||
| Matthew Rabinowitz | NTRA | Stock Option (right to buy) | Options Exercise | -100% | -58,292 | 0 | 06 Apr 2026 | Direct | ||
| Daniel Rabinowitz | NTRA | Common Stock | Sale | -3.6% | $1,707,814 | $203.31 | -8,400 | 224,885 | 01 Apr 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -1.99% | $606,899 | $202.30 | -3,000 | 147,882 | 01 Apr 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Options Exercise | 1.8% | 41,708 | 2,352,480 | 31 Mar 2026 | Direct | ||
| Matthew Rabinowitz | NTRA | Stock Option (right to buy) | Options Exercise | -41.7% | -41,708 | 58,292 | 31 Mar 2026 | Direct | ||
| Jonathan Sheena | NTRA | Common Stock | Sale | -3.44% | $149,868 | $199.82 | -750 | 21,032 | 20 Mar 2026 | By Caraluna 2 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -3.44% | $150,063 | $200.08 | -750 | 21,032 | 20 Mar 2026 | By Caraluna 1 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -1.17% | $608,370 | $198.17 | -3,070 | 259,255 | 18 Mar 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -2.12% | $9,813,883 | $196.28 | -50,000 | 2,310,772 | 16 Mar 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Options Exercise | 2.16% | 50,000 | 2,360,772 | 16 Mar 2026 | Direct | ||
| Matthew Rabinowitz | NTRA | Stock Option (right to buy) | Options Exercise | -33.3% | -50,000 | 100,000 | 16 Mar 2026 | Direct | ||
| Rowan E. Chapman | NTRA | Common Stock | Sale | -2.08% | $23,348 | $191.38 | -122 | 5,752 | 13 Mar 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -3.14% | $14,175,379 | $189.01 | -75,000 | 2,310,772 | 13 Mar 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Options Exercise | 3.25% | 75,000 | 2,385,772 | 13 Mar 2026 | Direct | ||
| Matthew Rabinowitz | NTRA | Stock Option (right to buy) | Options Exercise | -33.3% | -75,000 | 150,000 | 13 Mar 2026 | Direct | ||
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -3.14% | $14,294,119 | $190.59 | -75,000 | 2,310,772 | 12 Mar 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Options Exercise | 3.25% | 75,000 | 2,385,772 | 12 Mar 2026 | Direct | ||
| Matthew Rabinowitz | NTRA | Stock Option (right to buy) | Options Exercise | -25% | -75,000 | 225,000 | 12 Mar 2026 | Direct | ||
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -1.22% | $160,244 | $204.13 | -785 | 63,354 | 10 Mar 2026 | Direct |
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -3.47% | $1,147,838 | $204.13 | -5,623 | 156,607 | 10 Mar 2026 | Direct |
| Daniel Rabinowitz | NTRA | Common Stock | Sale | -0.74% | $356,212 | $204.13 | -1,745 | 233,285 | 10 Mar 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -0.05% | $25,925 | $204.13 | -127 | 262,325 | 10 Mar 2026 | Direct |
| John Fesko | NTRA | Common Stock | Sale | -0.37% | $144,322 | $204.13 | -707 | 189,199 | 10 Mar 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -0.6% | $186,781 | $204.13 | -915 | 150,882 | 10 Mar 2026 | Direct |
| Michael Burkes Brophy | NTRA | Common Stock | Award | 3.17% | 1,968 | 64,139 | 09 Mar 2026 | Direct | ||
| Steven Leonard Chapman | NTRA | Common Stock | Award | 3.59% | 5,623 | 162,230 | 09 Mar 2026 | Direct | ||
| Daniel Rabinowitz | NTRA | Common Stock | Award | 0.75% | 1,745 | 235,030 | 09 Mar 2026 | Direct | ||
| Jonathan Sheena | NTRA | Common Stock | Award | 0.1% | 258 | 262,452 | 09 Mar 2026 | Direct | ||
| John Fesko | NTRA | Common Stock | Award | 0.94% | 1,774 | 189,906 | 09 Mar 2026 | Direct | ||
| Solomon Moshkevich | NTRA | Common Stock | Award | 1.18% | 1,774 | 151,797 | 09 Mar 2026 | Direct | ||
| Daniel Rabinowitz | NTRA | Common Stock | Sale | -3.47% | $1,646,696 | $196.08 | -8,398 | 233,285 | 06 Mar 2026 | Direct |
| Daniel Rabinowitz | NTRA | Common Stock | Options Exercise | 2.37% | 5,598 | 241,683 | 06 Mar 2026 | Direct | ||
| Daniel Rabinowitz | NTRA | Stock Option (Right to Buy) | Options Exercise | -100% | -5,598 | 0 | 06 Mar 2026 | Direct | ||
| Jonathan Sheena | NTRA | Common Stock | Sale | -1.16% | $614,710 | $200.23 | -3,070 | 262,194 | 02 Mar 2026 | Direct |
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -2.46% | $790,095 | $200.02 | -3,950 | 156,607 | 02 Mar 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -1.96% | $599,545 | $199.85 | -3,000 | 150,023 | 02 Mar 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Options Exercise | 3.47% | 5,125 | 153,023 | 02 Mar 2026 | Direct | ||
| Solomon Moshkevich | NTRA | Stock Option (right to buy) | Options Exercise | -100% | -5,125 | 0 | 02 Mar 2026 | Direct | ||
| Jonathan Sheena | NTRA | Common Stock | Award | 0.8% | 2,103 | 265,264 | 27 Feb 2026 | Direct | ||
| Steven Leonard Chapman | NTRA | Common Stock | Award | 30.4% | 37,401 | 160,557 | 27 Feb 2026 | Direct | ||
| Solomon Moshkevich | NTRA | Common Stock | Award | 7.29% | 10,051 | 147,898 | 27 Feb 2026 | Direct | ||
| Matthew Rabinowitz | NTRA | Common Stock | Award | 1.31% | 29,920 | 2,310,772 | 27 Feb 2026 | Direct | ||
| Daniel Rabinowitz | NTRA | Common Stock | Award | 5.48% | 12,272 | 236,085 | 27 Feb 2026 | Direct | ||
| John Fesko | NTRA | Common Stock | Award | 5.64% | 10,051 | 188,132 | 27 Feb 2026 | Direct | ||
| Michael Burkes Brophy | NTRA | Common Stock | Award | 19.3% | 10,051 | 62,171 | 27 Feb 2026 | Direct | ||
| John Fesko | NTRA | Common Stock | Sale | -1.98% | $830,279 | $231.02 | -3,594 | 178,081 | 03 Feb 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -1.18% | $378,229 | $230.77 | -1,639 | 137,847 | 03 Feb 2026 | Direct |
| Daniel Rabinowitz | NTRA | Common Stock | Sale | -0.59% | $307,845 | $230.77 | -1,334 | 223,813 | 03 Feb 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.